Suven Pharmaceuticals receives credit ratings from CRISIL
Don't want to miss the best from Business Standard?
Suven Pharmaceuticals announced that CRISIL has assigned the following ratings to the bank facilities of the company.
Facilities Rating Long term bank facilitiesCRISIL A+/ Watch Developing (placed on rating watch with developing implications)
Short term bank facilities CRISIL A1+/ Watch Developing (placed on rating watch with developing implications)Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content